Has the region including the SOD1 gene been sequenced? What con... | Filo

Bardzo ważna zmiana w leczeniu stwardnienia zanikowego bocznego. Polska wprowadza wytyczne w diagnostyce ALS i terapie celowane

Investigational drug for genetic form of ALS improves disease’s molecular signs | Newswise

The ALS Canada Research Program has been funding the most promising ALS research in Canada for decades, paving the way for a global understanding of ALS, supporting researchers in developing effective treatments, and improving quality of life for individuals living with the disease. ALS Canada and Canadians played a crucial role in understanding SOD1 dysfunction in ALS, building the foundation that led to Qalsody (tofersen), the first therapy approved for the treatment of SOD1-ALS in the world.